Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) FCF Margin (2016 - 2020)

Syndax Pharmaceuticals has reported FCF Margin over the past 6 years, most recently at 4113.42% for Q4 2020.

  • Quarterly results put FCF Margin at 4113.42% for Q4 2020, down 76421.0% from a year ago — trailing twelve months through Sep 2021 was 22949.74% (down 1844374.0% YoY), and the annual figure for FY2025 was 187.5%, up 97340.0%.
  • FCF Margin for Q4 2020 was 4113.42% at Syndax Pharmaceuticals, up from 4827.7% in the prior quarter.
  • Over the last five years, FCF Margin for SNDX hit a ceiling of 1069.91% in Q4 2017 and a floor of 5648.28% in Q2 2020.
  • Median FCF Margin over the past 5 years was 3915.61% (2017), compared with a mean of 3715.02%.
  • Biggest five-year swings in FCF Margin: soared 2122293bps in 2016 and later crashed -289246bps in 2018.
  • Syndax Pharmaceuticals' FCF Margin stood at 3415.08% in 2016, then soared by 69bps to 1069.91% in 2017, then plummeted by -270bps to 3962.37% in 2018, then grew by 15bps to 3349.21% in 2019, then dropped by -23bps to 4113.42% in 2020.
  • The last three reported values for FCF Margin were 4113.42% (Q4 2020), 4827.7% (Q3 2020), and 5648.28% (Q2 2020) per Business Quant data.